| Year |
Title |
Authors |
volume |
issue |
| 2023 |
Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fibrosis |
Uchida Y., Ikeda S., Sekine A., katano T., Tabata E., Oda T., Okuda R., Kitamura H., Baba T., Komatsu S., Ogura T. |
59 |
1 |
| 2023 |
The current definition, epidemiology, animal models and a novel therapeutic strategy for aspiration pneumonia |
Teramoto S. |
60 |
1 |
| 2023 |
A systematic review and meta-analysis comparing the clinical characteristics and outcomes of COVID-19 and influenza patients on ECMO |
Chong W.H., Saha B.K., Medarov B.I. |
59 |
6 |
| 2023 |
Mechanisms underlying the sensation of dyspnea |
Fukushi I., Pokorski M., Okada Y. |
59 |
1 |
| 2022 |
Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells |
Yamaya M., Nishimura H., Deng X., Sugawara M., Watanabe O., Nomura K., Shimotai Y., Momma H., Ichinose M., Kawase T. |
58 |
3 |
| 2022 |
Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches |
Glass D.S., Grossfeld D., Renna H.A., Agarwala P., Spiegler P., Kasselman L.J., Glass A.D., DeLeon J., Reiss A.B. |
58 |
5 |
| 2022 |
Role of Nrf2 in the pathogenesis of respiratory diseases |
Mizumura K., Maruoka S., Shimizu T., Gon Y. |
58 |
1 |
